Deepak Bhatnagar

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Genome sequencing and analysis of Aspergillus oryzae

Masayuki Machida, Kiyoshi Asai, Motoaki Sano et al. · Nature · 2005 · 1.3K citations · Full text

Life Sciences, Genetics, Microbiology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

Michael I. Mackness, D. W. S. Harty, Deepak Bhatnagar et al. · Atherosclerosis · 1991 · 492 citations

Medicine, Biochemistry, Pharmacology +6

Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: a possible involvement of reactive oxygen species

Manisha Kale, N. Rathore, Sheila John et al. · Toxicology Letters · 1999 · 406 citations

Life Sciences, Biochemistry, Toxicology +17